New Vaccine Requirements, Anti-mRNA Narratives, and Disputed Gender-Affirming Care Report — The Monitor
This volume highlights how new vaccine requirements and the spread of anti-mRNA sentiments are fueling confusion and distrust. It also examines reactions to a federal report on gender-affirming care for minors and investigates how TikTok is being used to promote false health claims through deepfake personas targeting young women.
Disruption For the Sake of Disruption Is Not Innovation
By MIKE MAGEE “The technological leaps of the 1900s — microelectronics, antibiotics, chemotherapy, liquid-fueled rockets, Earth-observing satellites, lasers, LED lights, disease-resistant seeds and so forth — derived from science. But these technologies also spent years being improved, tweaked, recombined and modified to make them achieve the scale and impact necessary for innovations.” Jon Gertner, author of “The Idea…
Will ICER’s ‘shared savings’ approach decrease value-based prices most for the most severe diseases?
That is the title of a paper recently accepted for publication by Value in Health with co-authors Shanshan Wang, Khounish Sharma, Kathryn Spurrier, Robert J. Nordyke. The abstract is below. Objectives To identify the types of disease most likely to be impacted by the Institute for Clinical and Economic Review’s (ICER) shared savings assumptions. Methods…
Sean Bell, Spring Health
Sean Bell is head of new ventures at Spring Health, a very well-funded mental health company. They’ve built a tech platform that its providers (both contractors and FT employees) are on, and spend a lot of time using machine learning to match patients to therapists, to augment the care and also measure the impact of…
Gilead Sciences Gains In Vivo Cell Therapy Capability With $350M Interius Bio Acquisition
Gilead Sciences, whose Kite subsidiary was one of the pioneers of ex vivo cancer cell therapy, is joining the pursuit of in vivo therapies with the acquisition of startup Interius BioTherapeutics. The deal follows AstraZeneca and AbbVie acquisitions this year for in vivo cell therapy developers. The post Gilead Sciences Gains In Vivo Cell Therapy…
Bancos, primera línea de batalla contra los fraudes financieros a adultos mayores
La primera llamada llegó justo antes del Día de Acción de Gracias del año pasado. No reconoció el número, pero respondió de todos modos. “La persona dijo que era un oficial del Departamento de Investigaciones Criminales que trabajaba en un caso de tráfico de drogas y lavado de dinero”, recordó la mujer. Parecía saber mucho…
Families USA Poll: Voters Most Concerned About Healthcare Costs
A new poll finds U.S. voters far more concerned about healthcare costs than any other major issue
Gold Carding Programs Are Meant to Improve Prior Authorization. Are They Working?
Several states and insurers have gold carding programs to streamline prior authorization. However, some say they’re falling short. The post Gold Carding Programs Are Meant to Improve Prior Authorization. Are They Working? appeared first on MedCity News.
Actionable AI in Clinical Settings: Trust and Transparency as the Core Operating System
The real promise of AI agents lies not in their intelligence but in their ability to deliver empathy at scale. By taking on repetitive tasks and restoring capacity to the people who deliver care, AI can help rebalance the system toward its original, deeply human purpose. The post Actionable AI in Clinical Settings: Trust and…